Cambridge BHF Centre of Research Excellence
The British Heart Foundation (BHF) has awarded the University of Cambridge £5 million to expand and accelerate its pioneering work through the Cambridge BHF Centre of Research Excellence 2024-2029.
The renewed Centre is led by Prof Martin Bennett and managed by Dr Jane Sugars and brings together 24 world-leading research groups across the University of Cambridge and several interdisciplinary institutes: Wellcome Trust Sanger Institute, the Wellcome-MRC Cambridge Stem Cell Institute, the MRC Mitochondrial Biology Unit , the Institute of Metabolic Science and THIS Institute.
The Centre provides a focus for cardiovascular researchers in Cambridge and strengthens internal collaborations through funding for studentships, fellowships, and pilot projects. It also supports the integration of research groups within the new Victor Phillip Dahdaleh Heart and Lung Research Institute (HLRI).
The overarching aim of the Centre is to advance understanding of cardiovascular conditions by applying our combined expertise in generating assumption-free approaches.
The Centre has five main research themes:
- Mobilising and translating discoveries from multi-omic cohorts
- Targeting inflammation in cardiovascular disease
- Advanced therapeutics for cardiac repair and regeneration
- Cardiometabolic syndromes: Exposome and molecular mechanisms linking Obesity, Diabetes, HFpEF, NAFLD, and NASH
- Applied Cardiovascular Health Research
Research is carried out by the BHF Cambridge Centre of Excellence (CRE) Theme leads and Co-applicants
The Centre is led by the BHF Cambridge Centre of Excellence (CRE) Steering Group & Scientific Advisory Board representing the main research themes above.
Funding recipients: please acknowledge support from the Centre in your publications using the appropriate code:
|